HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Mori Selected Research

tristearin

8/2001Comparative effects of dietary fat types on hepatic enzyme activities related to the synthesis and oxidation of fatty acid and to lipogenesis in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Mori Research Topics

Disease

14Neoplasms (Cancer)
06/2013 - 05/2000
11Infections
07/2022 - 03/2000
9Hypertension (High Blood Pressure)
07/2016 - 01/2000
7Insulin Resistance
05/2016 - 04/2000
7Fibrosis (Cirrhosis)
03/2009 - 08/2000
5Necrosis
06/2011 - 01/2000
5Glomerulonephritis
09/2007 - 07/2000
5Disseminated Intravascular Coagulation
10/2001 - 01/2000
4Obesity
05/2016 - 03/2001
4Proteinuria
01/2012 - 07/2000
4Chronic Kidney Failure (Chronic Renal Failure)
04/2011 - 07/2001
4Inflammation (Inflammations)
04/2011 - 09/2000
4Pain (Aches)
09/2010 - 12/2000
4Type 2 Diabetes Mellitus (MODY)
04/2006 - 04/2000
4Psychomotor Agitation (Akathisia)
11/2001 - 01/2000
3Bone Resorption
01/2018 - 02/2001
3Stomach Neoplasms (Stomach Cancer)
03/2011 - 08/2000
3Shock
02/2011 - 11/2000
3Carcinoma (Carcinomatosis)
01/2008 - 05/2000
3Esophageal Neoplasms (Esophageal Cancer)
01/2008 - 01/2002
3Neoplasm Metastasis (Metastasis)
08/2006 - 01/2000
3Hypertrophy
09/2001 - 07/2000
3Thrombotic Thrombocytopenic Purpura
07/2001 - 09/2000
2Vomiting
01/2019 - 01/2018
2Nausea
01/2019 - 01/2018
2Herpes Zoster
01/2017 - 04/2013
2Stomach Ulcer (Gastric Ulcer)
01/2017 - 02/2007
2Diabetes Mellitus
01/2016 - 09/2001
2Exanthema (Rash)
09/2015 - 10/2012
2Hypoxia (Hypoxemia)
04/2014 - 06/2003
2Hypersensitivity (Allergy)
10/2012 - 02/2007
2Sepsis (Septicemia)
12/2011 - 10/2001
2Disease Progression
11/2011 - 06/2011
2Ischemia
06/2011 - 11/2000
2Systemic Scleroderma (Systemic Sclerosis)
06/2011 - 02/2008
2Amyloidosis
06/2011 - 05/2001
2Respiratory Insufficiency (Respiratory Failure)
04/2011 - 03/2005
2Renal Insufficiency (Renal Failure)
04/2011 - 03/2007
2Malnutrition (Nutritional Deficiencies)
04/2011 - 06/2001
2AIDS-Related Complex (ARC)
07/2010 - 10/2009
2Pathologic Constriction (Stenosis)
01/2007 - 06/2005
2Barrett Esophagus (Barrett's Esophagus)
06/2006 - 01/2002
2Hyperglycemia
06/2005 - 09/2001
2Abdominal Obesity
06/2005 - 11/2004
2Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2005 - 08/2001

Drug/Important Bio-Agent (IBA)

8Glucose (Dextrose)FDA LinkGeneric
05/2016 - 12/2000
6Insulin (Novolin)FDA Link
10/2012 - 04/2000
6Proteins (Proteins, Gene)FDA Link
03/2007 - 04/2000
5AntigensIBA
04/2013 - 03/2000
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2006 - 05/2001
5Triglycerides (Triacylglycerol)IBA
06/2005 - 07/2001
5Hydrocortisone (Cortisol)FDA LinkGeneric
08/2002 - 01/2000
5Dacarbazine (DIC)FDA LinkGeneric
10/2001 - 01/2000
4CollagenIBA
10/2017 - 05/2000
4Messenger RNA (mRNA)IBA
01/2004 - 04/2001
3Pharmaceutical PreparationsIBA
07/2016 - 11/2000
3LipidsIBA
05/2016 - 07/2000
3AntibodiesIBA
04/2011 - 02/2000
3Gonadotropin-Releasing Hormone (GnRH)FDA Link
07/2010 - 06/2001
3Immunoglobulin G (IgG)IBA
01/2007 - 02/2001
3Complementary DNA (cDNA)IBA
06/2006 - 06/2001
3CytokinesIBA
03/2005 - 01/2003
3Interleukin-6 (Interleukin 6)IBA
12/2002 - 07/2000
3Collagen Type I (Type I Collagen)IBA
10/2001 - 01/2001
3DNA (Deoxyribonucleic Acid)IBA
09/2001 - 02/2001
3Formaldehyde (Formol)FDA Link
08/2001 - 02/2000
3Tissue Plasminogen Activator (Alteplase)FDA Link
07/2001 - 07/2000
3thiamine triphosphorate (TTP)IBA
07/2001 - 09/2000
3SaltsIBA
06/2001 - 04/2001
3Hemostatics (Antihemorrhagics)IBA
01/2001 - 07/2000
2AntiemeticsIBA
01/2019 - 01/2018
21- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA
01/2017 - 09/2015
2Immunologic Factors (Immunomodulators)IBA
01/2017 - 04/2013
2p38 Mitogen-Activated Protein KinasesIBA
07/2016 - 05/2016
2Angiotensin IIIBA
07/2016 - 10/2001
2Nonesterified Fatty Acids (NEFA)IBA
05/2016 - 03/2005
2CreatinineIBA
01/2014 - 01/2007
2Biological ProductsIBA
06/2013 - 01/2001
2Biomarkers (Surrogate Marker)IBA
04/2013 - 03/2011
2Immunoglobulin E (IgE)IBA
10/2012 - 01/2007
2cilnidipineIBA
01/2012 - 06/2001
2Adrenal Cortex Hormones (Corticosteroids)IBA
04/2011 - 07/2000
2Anti-Bacterial Agents (Antibiotics)IBA
04/2011 - 06/2001
2antiglomerular basement membrane antibodyIBA
04/2011 - 09/2007
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
04/2011 - 12/2006
2KisspeptinsIBA
07/2010 - 10/2009
2Hormones (Hormone)IBA
10/2009 - 08/2001
2Cisplatin (Platino)FDA LinkGeneric
01/2008 - 01/2000
2LigandsIBA
09/2007 - 08/2000
2Chaperonin 60IBA
05/2006 - 09/2000
2Interleukin-18 (Interleukin 18)IBA
05/2006 - 03/2005
2Inosine Triphosphate (ITP)IBA
12/2005 - 02/2001
2HDL CholesterolIBA
06/2005 - 07/2001

Therapy/Procedure

11Therapeutics
11/2015 - 01/2000
6Drug Therapy (Chemotherapy)
01/2019 - 01/2000
4Renal Dialysis (Hemodialysis)
04/2011 - 09/2000
4Radiotherapy
01/2008 - 01/2000
2Aftercare (After-Treatment)
07/2022 - 06/2001
2Lasers (Laser)
02/2011 - 01/2009
2Stents
01/2007 - 06/2005